Background: Thrombocytopenic patients who acquire Stenotrophomonas maltophilia (SM) respiratory infection often develop pulmonary hemorrhage (PH), resulting in a high respiratory failure rate and increased mortality. This study aimed to evaluate risk factors for PH and develop an index measuring serial platelet deficit to predict PH in patients with SM respiratory infection.Methods: Data of patients with both SM isolated from sputum/endotracheal suction culture and thrombocytopenia (platelet count < 150x103 /μL) who were treated at National Cheng Kung University Hospital during 2018-2020 were extracted from electronic medical records and analyzed retrospectively. SM respiratory infection was defined as positive bacterial isolates plus respiratory infection symptoms. Clinical parameters and laboratory findings were compared between PH and non-PH groups. The platelet dissimilarity index (d-index) was calculated by accumulating differences between the actual and the lowest normal level of platelet count in each patient at different time points.Results: Among 437 SM respiratory infection cases, 125 (28.6%) patients developed PH. Patients with PH had increased prothrombin time/international normalized ratio (PT/INR), lower platelet count, and higher platelet d-index. Multivariate analysis revealed that extreme thrombocytopenia (platelet count < 50x103 /μL) is a common independent risk factor for PH and mortality. The performance of platelet deficit and d-index varied between patients with different comorbidities. Performance of single time-point platelet deficit to predict PH is more reliable in patients with hematology/oncology and liver disease (area under curve 0.705-0.757), while performance of d-index is more reliable in patients with sepsis/treatment and various other groups (0.711-0.816).Conclusions: Prolonged and extreme thrombocytopenia is a determinant risk factor for PH in patients with SM respiratory infection. Given the complexity of causes of thrombocytopenia and associated comorbidities, different strategies should be applied to assess the degree of thrombocytopenia when evaluating the risk for PH.